Eko Analysis Software vs Zio AT ECG Monitoring System

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Eko Health
VS
by iRhythm Technologies, Inc.

AI Verdict

Eko Analysis Software is designed for immediate, point-of-care assessment of heart sounds and short-term ECGs, aiding in the early detection of conditions like heart murmurs and atrial fibrillation. In contrast, the Zio AT ECG Monitoring System provides continuous, long-term wearable ECG monitoring for up to 14 days, specializing in the comprehensive detection of various symptomatic and asymptomatic arrhythmias. While both utilize AI for cardiac analysis and remote monitoring, they serve distinct clinical needs regarding monitoring duration and diagnostic focus.

Choose Eko Analysis Software if…

Choose Eko Analysis Software if you require an immediate, AI-assisted screening tool for cardiovascular conditions during routine physical examinations or point-of-care assessments. It excels at real-time auscultation with AI for early detection of heart murmurs and atrial fibrillation, providing instant insights to guide further diagnostic steps.

View Eko Analysis Software →

Choose Zio AT ECG Monitoring System if…

Choose Zio AT ECG Monitoring System if your primary need is continuous, long-term ECG monitoring to detect intermittent or asymptomatic arrhythmias over an extended period. This wearable system is ideal for patients requiring up to 14 days of uninterrupted recording and real-time data transmission for comprehensive diagnostic reporting.

View Zio AT ECG Monitoring System →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Eko Analysis Software Zio AT ECG Monitoring System
Pricing Unknown Contact for pricing
Deployment Unknown Cloud-based (data analytics and clinician portal)
BAA Available Yes AI-estimated Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Eko Analysis Software

Eko Analysis Software integrates directly with digital stethoscopes and a mobile app, offering an intuitive and interactive experience for clinicians at the point of care. Its freemium model also provides easy access to basic features, lowering the barrier to initial use.

Clinical Value

Zio AT ECG Monitoring System

While both tools offer significant clinical value, the Zio AT ECG Monitoring System provides continuous, long-term ECG monitoring for up to 14 days, enabling the detection of both symptomatic and asymptomatic arrhythmias. This extended monitoring capability offers a more comprehensive and definitive diagnostic picture compared to Eko's point-of-care screening.

Pricing & Value

Eko Analysis Software

Eko Analysis Software features a transparent freemium model, allowing users to access basic features for free and clearly understand the cost of full AI-powered capabilities through a subscription. In contrast, Zio AT's pricing is not publicly disclosed, requiring direct contact, which makes it harder to assess its value proposition upfront.

Enterprise Readiness

Zio AT ECG Monitoring System

The Zio AT ECG Monitoring System offers a comprehensive, end-to-end service for long-term cardiac monitoring, including a wearable device, wireless data transmission, and dedicated clinician and patient portals. This integrated ecosystem is well-suited for managing large patient populations within enterprise healthcare systems, indicating strong enterprise readiness.

Innovation

Zio AT ECG Monitoring System

Zio AT's innovation lies in its wearable patch for continuous, long-term ECG recording (up to 14 days) combined with a sophisticated deep-learned AI algorithm for comprehensive arrhythmia detection and real-time data transmission. This pushes the boundaries of extended diagnostic monitoring, capturing transient events that might otherwise be missed.

Support & Docs

Eko Analysis Software

Eko provides a highly organized and accessible Help Center with a wide array of self-service resources, including user manuals, FAQs, troubleshooting guides, how-to videos, and clinical education materials. They also offer clear direct contact options for both individual and enterprise users.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Eko Analysis Software Zio AT ECG Monitoring System
Tool Name Eko Analysis Software Zio AT ECG Monitoring System
Company Eko Devices iRhythm Technologies, Inc.
Description FDA-cleared AI-powered tool that integrates with Eko's digital stethoscopes and mobile app to assist clinicians in the early detection of cardiovascular diseases like heart murmurs and atrial fibrillation. FDA-cleared, wearable mobile cardiac telemetry (MCT) service offering continuous, AI-powered ECG monitoring for long-term arrhythmia detection and comprehensive reporting.
Key AI Detection Capabilities FDA-cleared AI for heart murmur detection, FDA-cleared AI for atrial fibrillation (AFib) detection, Detection of normal sinus rhythm FDA-cleared deep-learned AI algorithm (ZEUS System) for arrhythmia detection
Primary Device Type Integrates with Eko's digital stethoscopes and mobile app Wearable Zio AT patch
Recording Duration Recording, playback, and annotation of heart sounds and ECGs (duration not specified) Continuous, uninterrupted ECG recording for up to 14 days

Videos

Demos, reviews, and walkthroughs featuring Eko Analysis Software and Zio AT ECG Monitoring System.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Eko Analysis Software is an FDA-cleared AI-powered tool that assists clinicians in the early detection of cardiovascular diseases like heart murmurs and atrial fibrillation, and also detects normal sinus rhythm. The Zio AT ECG Monitoring System is an FDA-cleared, wearable mobile cardiac telemetry (MCT) service offering continuous, AI-powered ECG monitoring for long-term arrhythmia detection and comprehensive reporting.
Eko Analysis Software integrates with Eko's digital stethoscopes and mobile app for wireless auscultation, recording, playback, and annotation of heart sounds and ECGs. The Zio AT system utilizes a wearable Zio AT patch for continuous, uninterrupted ECG recording for up to 14 days, with real-time data transmission via a wireless gateway.
Eko Analysis Software features FDA-cleared AI for heart murmur detection, atrial fibrillation (AFib) detection, and normal sinus rhythm, along with the calculation of cardiac time intervals. The Zio AT system uses an FDA-cleared deep-learned AI algorithm (ZEUS System) for the detection of symptomatic and asymptomatic cardiac events and arrhythmias.
Eko Analysis Software is categorized for Cardiology AI and Wearables & Remote Monitoring (RPM), supporting specialties such as Cardiology, Emergency Medicine, and Internal Medicine. The Zio AT ECG Monitoring System is primarily designed for Cardiology, focusing on comprehensive long-term arrhythmia monitoring.
With Eko Analysis Software, clinicians can record, playback, and annotate heart sounds and ECGs, with secure cloud-based storage of recordings and PDF reports available with a paid subscription. The Zio AT system provides comprehensive end-of-wear reports and utilizes the ZioSuiteu00ae clinician portal and mobile app for patient management and report interpretation.

Backers

Who funded each tool's parent company.

Eko Analysis Software

AI Tool Finder
AI-powered search. Results may not be comprehensive.